Elisabeth Garnier-Andre
Nantes, 44000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study.
Journal: The Journal of antimicrobial chemotherapy
Published: February 18, 2026
False-negative result in fourth-generation HIV screening tests after weak detection of p24 antigen in the context of inappropriate post-exposure prophylaxis use: a case report.
Journal: The Journal of antimicrobial chemotherapy
Published: January 19, 2026
The DePASS initiative in healthcare access units: Do not miss the opportunity to detect HIV, HBV, and HCV.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 24, 2025
Use of genotypic HIV DNA testing: a DELPHI-type consensus.
Journal: The Journal of antimicrobial chemotherapy
Published: November 02, 2023
Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial.
Journal: AIDS research and therapy
Published: August 18, 2021
Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.
Journal: International journal of antimicrobial agents
Published: February 10, 2020
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: October 03, 2019
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
Journal: The Journal of antimicrobial chemotherapy
Published: October 16, 2017
Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study).
Journal: Medecine et maladies infectieuses
Published: September 11, 2017
Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy.
Journal: Journal of virological methods
Published: May 17, 2017
Last Updated: 09/26/2026